GENETIC-HETEROGENEITY OF HEPATOCELLULAR-CARCINOMA

被引:154
作者
UNSAL, H
YAKICIER, C
MARCAIS, C
KEW, M
VOLKMANN, M
ZENTGRAF, H
ISSELBACHER, KJ
OZTURK, M
机构
[1] CTR LEON BERARD,INSERM,CJF 9302,ONCOL MOLEC LAB,F-69008 LYON,FRANCE
[2] MASSACHUSETTS GEN HOSP,CTR CANC,BOSTON,MA 02129
[3] UNIV WITWATERSRAND,JOHANNESBURG,SOUTH AFRICA
[4] UNIV HEIDELBERG,DEPT INTERNAL MED,W-6900 HEIDELBERG,GERMANY
[5] DEUTSCH KREBSFORSCHUNGSZENTRUM,HEIDELBERG,GERMANY
关键词
P53 TUMOR SUPPRESSOR GENE; HEPATITIS B VIRUS; AFLATOXINS; MUTATION; LIVER CANCER;
D O I
10.1073/pnas.91.2.822
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We studied 80 hepatocellular carcinomas from three continents For p53 gene (TP53) mutations and hepatitis B virus (HBV) sequences. p53 mutations were frequent in tumors from Mozambique but not in tumors from South Africa, China, and Germany. Independent of geographic origin, most tumors were positive for HBV sequences. X gene coding sequences of HBV were detected in 78% of tumors, whereas viral sequences in the surface antigen- and core antigen-encoding regions were present in less than 45% of tumors. These observations indicate that hepatocellular carcinomas are genetically heterogeneous. Mozambican-type of hepatocellular carcinomas are characterized by a high incidence of p53 mutations related to aflatoxins. In other tumors, the rarity of p53 mutations combined with the frequent presence of viral X gene coding sequences suggests a possible interference of HBV with the wild-type p53 function.
引用
收藏
页码:822 / 826
页数:5
相关论文
共 49 条
[1]   CONTROLLED SYNTHESIS OF HBSAG IN A DIFFERENTIATED HUMAN-LIVER CARCINOMA-DERIVED CELL-LINE [J].
ADEN, DP ;
FOGEL, A ;
PLOTKIN, S ;
DAMJANOV, I ;
KNOWLES, BB .
NATURE, 1979, 282 (5739) :615-616
[2]  
BEASLEY RP, 1982, HEPATOLOGY, V2, pS21
[3]   SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA [J].
BRESSAC, B ;
KEW, M ;
WANDS, J ;
OZTURK, M .
NATURE, 1991, 350 (6317) :429-431
[4]   LOW-FREQUENCY OF P53 MUTATIONS OBSERVED IN A DIVERSE COLLECTION OF PRIMARY HEPATOCELLULAR CARCINOMAS [J].
BUETOW, KH ;
SHEFFIELD, VC ;
ZHU, MH ;
ZHOU, TL ;
SHEN, FM ;
HINO, O ;
SMITH, M ;
MCMAHON, BJ ;
LANIER, AP ;
LONDON, WT ;
REDEKER, AG ;
GOVINDARAJAN, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) :9622-9626
[5]   ANALYSIS OF THE P53 TUMOR-SUPPRESSOR GENE IN HEPATOCELLULAR CARCINOMAS FROM BRITAIN [J].
CHALLEN, C ;
LUNEC, J ;
WARREN, W ;
COLLIER, J ;
BASSENDINE, MF .
HEPATOLOGY, 1992, 16 (06) :1362-1366
[6]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[7]   HIGH PREVALENCE OF MUTATIONS AT CODON 249 OF THE P53 GENE IN HEPATOCELLULAR CARCINOMAS FROM SENEGAL [J].
COURSAGET, P ;
DEPRIL, N ;
CHABAUD, M ;
NANDI, R ;
MAYELO, V ;
LECANN, P ;
YVONNET, B .
BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1395-1397
[8]  
CRAIG JR, 1989, ATLAS TUMOR PATHOLOG
[9]   CLONAL P53 MUTATION IN PRIMARY CERVICAL-CANCER - ASSOCIATION WITH HUMAN-PAPILLOMAVIRUS-NEGATIVE TUMORS [J].
CROOK, T ;
WREDE, D ;
TIDY, JA ;
MASON, WP ;
EVANS, DJ ;
VOUSDEN, KH .
LANCET, 1992, 339 (8801) :1070-1073
[10]   PROPERTIES OF P53 MUTATIONS DETECTED IN PRIMARY AND SECONDARY CERVICAL CANCERS SUGGEST MECHANISMS OF METASTASIS AND INVOLVEMENT OF ENVIRONMENTAL CARCINOGENS [J].
CROOK, T ;
VOUSDEN, KH .
EMBO JOURNAL, 1992, 11 (11) :3935-3940